ID

33048

Descrizione

This form contains a form to document the randomisation number, investigational products and the pharmacokinetics. To be assessed at the visits V1-3. Study ID: 103629 Clinical Study ID: TRX103629 Study Title: An open-label, randomized, 3-period crossover study to evaluate sumatriptan and naproxen pharmacokinetics for a combination tablet product containing sumatriptan/naproxen sodium followed by IMITREX™ (sumatriptan succinate) Injection 4mg administered using the IMITREX STATdose System and a sumatriptan/naproxen sodium tablet followed by IMITREX (sumatriptan succinate) Injection 6mg administered using the STATdose system compared with an IMITREX tablet 100mg followed by an IMITREX tablet 100mg Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00875784 Clinicaltrials.gov link: https://clinicaltrials.gov/ct2/show/NCT00875784 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: sumatriptan Trade Name: Imitrex ,Imiject ,Imigran; Imitrex,Imiject,Imigran Study Indication: Migraine Disorders

collegamento

https://clinicaltrials.gov/ct2/show/NCT00875784

Keywords

versioni (3)
  1. 18/11/18 18/11/18 -
  2. 25/11/18 25/11/18 -
  3. 25/11/18 25/11/18 -
Titolare del copyright

GlaxoSmithKline

Caricato su

25 novembre 2018

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Sumatriptan pharmacokinetics for TREXIMA/IMITREX NCT00875784

Inglese

Randomisation Number, Investigational Products, Pharmacokinetics Blood

1 moduli  
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Date of Visit
Descrizione

Date of Visit

Tipo di dati

date

Alias
UMLS CUI [1]
C1320303
Visit Type
Descrizione

Visit Type

Tipo di dati

text

Alias
UMLS CUI [1]
C3641100
Randomisation Number (Only Visit 1)
Descrizione

Randomisation Number (Only Visit 1)

Alias
UMLS CUI-1
C1300638
UMLS CUI-2
C0034656
Was the subject able to be randomised?
Descrizione

Subject's randomisation

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1300638
UMLS CUI [1,2]
C0034656
In case the subject was able to be randomised, provide: Randomisation number
Descrizione

Randomisation number

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1300638
UMLS CUI [1,2]
C0034656
In case the subject was able to be randomised, provide: Date of randomisation
Descrizione

Date of randomisation

Tipo di dati

date

Alias
UMLS CUI [1]
C0034656
Investigational Product
Descrizione

Investigational Product

Alias
UMLS CUI-1
C0304229
Date/time of dose
Descrizione

Date/time of dose

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C1264639
Treatment Confirmation
Descrizione

Treatment Confirmation

Alias
UMLS CUI-1
C0750484
UMLS CUI-2
C0087111
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
Descrizione

Receivement of the correct treatment

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0750484
UMLS CUI [1,2]
C0087111
In case the subject did not receive the correct treatment: record reason(s)
Descrizione

Reason(s) in case the subject did not receive the correct treatment

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C3827420
UMLS CUI [1,3]
C0392360
Dosing Date and Time
Descrizione

Dosing Date and Time

Alias
UMLS CUI-1
C0178602
UMLS CUI-2
C1264639
Dosing date/time
Descrizione

Dosing date/time

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C0178602
UMLS CUI [1,2]
C1264639
Pharmacokinetics Blood
Descrizione

Pharmacokinetics Blood

Alias
UMLS CUI-1
C0031328
UMLS CUI-2
C0005767
Planend relative time
Descrizione

Planned relative time of blood sample collection for pharmacokinetics analysis

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0439564
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Actual time
Descrizione

To be assessed for all timepoints up to 4 hours post-dose (included)

Tipo di dati

time

Alias
UMLS CUI [1,1]
C0040223
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Actual date/time
Descrizione

To be assessed for all timepoints from 6 hours post-dose on (included).

Tipo di dati

datetime

Alias
UMLS CUI [1,1]
C1264639
UMLS CUI [1,2]
C0031328
UMLS CUI [1,3]
C0005834
Ritorna all'inizio della pagina

Similar models

Randomisation Number, Investigational Products, Pharmacokinetics Blood

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Item
Visit Type
text
C3641100 (UMLS CUI [1])
Visit Type
Code List
Visit Type
CL Item
V1 (V1)
CL Item
V2 (V2)
CL Item
V3 (V3)
Item Group
Randomisation Number (Only Visit 1)
C1300638 (UMLS CUI-1)
C0034656 (UMLS CUI-2)
Subject's randomisation
Item
Was the subject able to be randomised?
boolean
C1300638 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Randomisation number
Item
In case the subject was able to be randomised, provide: Randomisation number
text
C1300638 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
Date of randomisation
Item
In case the subject was able to be randomised, provide: Date of randomisation
date
C0034656 (UMLS CUI [1])
Item Group
Investigational Product
C0304229 (UMLS CUI-1)
Date/time of dose
Item
Date/time of dose
datetime
C0304229 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Treatment Confirmation
C0750484 (UMLS CUI-1)
C0087111 (UMLS CUI-2)
Receivement of the correct treatment
Item
Did the subject receive the correct treatment (e.g., treatment which the subject was assigned to) during this dosing interval?
boolean
C0750484 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Reason(s) in case the subject did not receive the correct treatment
Item
In case the subject did not receive the correct treatment: record reason(s)
text
C0087111 (UMLS CUI [1,1])
C3827420 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,3])
Item Group
Dosing Date and Time
C0178602 (UMLS CUI-1)
C1264639 (UMLS CUI-2)
Dosing date/time
Item
Dosing date/time
datetime
C0178602 (UMLS CUI [1,1])
C1264639 (UMLS CUI [1,2])
Item Group
Pharmacokinetics Blood
C0031328 (UMLS CUI-1)
C0005767 (UMLS CUI-2)
Item
Planend relative time
text
C0439564 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Timepoint
Code List
Planend relative time
CL Item
Pre-dose (Pre-dose)
CL Item
0.5 hours (0.5 hours)
CL Item
0.75 hours (0.75 hours)
CL Item
1 hour (1 hour)
CL Item
1.5 hours (1.5 hours)
CL Item
2 hours (2 hours)
CL Item
2.17 hours (2.17 hours)
CL Item
2.25 hours (2.25 hours)
CL Item
2.5 hours (2.5 hours)
CL Item
2.75 hours (2.75 hours)
CL Item
3 hours (3 hours)
CL Item
4 hours (4 hours)
CL Item
6 hours (6 hours)
CL Item
8 hours (8 hours)
CL Item
10 hours (10 hours)
CL Item
12 hours (12 hours)
CL Item
14 hours (14 hours)
CL Item
24 hours (24 hours)
CL Item
48 hours (48 hours)
CL Item
72 hours (72 hours)
Actual time of blood sample collection for pharmacokinetics analysis
Item
Actual time
time
C0040223 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Actual date/time of blood sample collection for pharmacokinetics analysis
Item
Actual date/time
datetime
C1264639 (UMLS CUI [1,1])
C0031328 (UMLS CUI [1,2])
C0005834 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial